News - Advair, Relvar

Filter

Current filters:

AdvairRelvar

Popular Filters

Global asthma treatment market to reach $21.6 billion by 2019

09-10-2013

The global asthma treatment market is estimated to reach a value of $21.6 billion by 2019, due not only…

GlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRelvarRespiratory and Pulmonary

Great expectations for GlaxoSmithKline R&D newsflow

13-12-2012

Essentially, analysts at Panmure Gordon & Co anticipate a lot of pipeline newsflow from UK pharma giant…

AdvairdarapladibFinancialGlaxoSmithKlineMAGE-A3PharmaceuticalResearch

Asthma preventive drugs market led by GlaxoSmithKline's Advair

26-11-2012

The asthma preventive drugs market has been forecast to increase at a compound annual growth rate (CAGR)…

AdvairAstraZenecaGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicort

New LABA/LAMA drugs set to fracture COPD market

10-10-2012

The drug market for chronic obstructive pulmonary disease (COPD) therapies will become more fractured…

AdvairBoehringer IngelheimGlaxoSmithKlineGlobalMarkets & MarketingPfizerPharmaceuticalRespiratory and PulmonarySpiriva

Relovair COPD and asthma filings on track despite more mixed trial results

26-03-2012

As well as announcing new mixed clinical trial data, UK pharma giant GlaxoSmithKline (LSE: GSK) and US…

AdvairEuropeGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRelovairRespiratory and PulmonaryTheravance

Company Spotlight

Fibrotech

Fibrotech

Back to top